|
Volumn 307, Issue 1, 2002, Pages 70-75
|
Development of a high-throughput fluorescence polarization assay for Bcl-xL
|
Author keywords
Apoptosis; Bad peptide; Bcl xL; BH3 domain; Fluorescence polarization assay
|
Indexed keywords
BARIUM COMPOUNDS;
CELL DEATH;
CONTROLLED DRUG DELIVERY;
DIAGNOSIS;
DIMETHYL SULFOXIDE;
DRUG PRODUCTS;
FLUORESCENCE;
POLARIZATION;
SIGNAL TO NOISE RATIO;
ANTI-APOPTOTIC PROTEIN;
BCL-XL;
BH3 DOMAIN;
BIOLOGICAL FUNCTIONS;
COMPETITION ASSAYS;
FLUORESCENCE POLARIZATION;
HIGH THROUGHPUT SCREENING;
PLATE-TO-PLATE VARIABILITIES;
PEPTIDES;
DIMETHYL SULFOXIDE;
FLUORESCEIN;
MUTANT PROTEIN;
PEPTIDE;
PROTEIN BAD;
PROTEIN BAK;
PROTEIN BAX;
PROTEIN BCL XL;
PROTEIN INHIBITOR;
BAD PROTEIN, HUMAN;
BAX PROTEIN, HUMAN;
BCL2L1 PROTEIN, HUMAN;
CARRIER PROTEIN;
FLUORESCENT DYE;
ONCOPROTEIN;
PEPTIDE FRAGMENT;
PROTEIN BCL 2;
PROTEIN BCL X;
APOPTOSIS;
ARTICLE;
FLUORESCENCE POLARIZATION IMMUNOASSAY;
GENE MUTATION;
HUMAN;
IC 50;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
PROTEIN PROTEIN INTERACTION;
SEQUENCE HOMOLOGY;
SIGNAL NOISE RATIO;
BINDING COMPETITION;
CHEMISTRY;
FLUORESCENCE POLARIZATION;
METHODOLOGY;
MUTATION;
BCL-2-ASSOCIATED X PROTEIN;
BCL-ASSOCIATED DEATH PROTEIN;
BCL-X PROTEIN;
BINDING, COMPETITIVE;
CARRIER PROTEINS;
FLUORESCENCE POLARIZATION;
FLUORESCENT DYES;
HUMANS;
MUTATION;
PEPTIDE FRAGMENTS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
|
EID: 0036667918
PISSN: 00032697
EISSN: None
Source Type: Journal
DOI: 10.1016/S0003-2697(02)00028-3 Document Type: Article |
Times cited : (77)
|
References (19)
|